Major Changes Made by Criteria Committee of the New York Heart Association

Harvey, Réjane M.; Doyle, Emily; Ellis, Kasey; Farber, Saul J.; Ferrer, M. Irené; Fischel, Ellis; Fox, Andy; Griffiths, Susan; Jameson, Angela; Killip, Thomas; Kuschner, Marvin; Malm, James R.

doi:10.1161/01.cir.49.3.390

Cited by 45 publications

(6 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Severity of condition, risk, and criteria for intervention were measured by the following systems: Canadian Cardiovascular Society functional classification for angina related limitation on activities9; New York Heart Association scale10; Parsonnet 1 and 2 clinical risk scores for heart surgery11 12 (versions with and without the age correction (bias) were used for comparison); De Bono clinical priority criteria for cardiac catheterisation and PTCA13; and the New Zealand priority scores for urgency of CABG 56 The cardiologists and cardiac surgeons who developed and tested the New Zealand criteria agreed to accept a specific numerical threshold as indicative of reasonable levels of public service provision.…”

Section: Methodsmentioning

confidence: 99%

Equity in access to exercise tolerance testing, coronary angiography, and coronary artery bypass grafting by age, sex and clinical indications

Bowling

Bond²,

McKee³

et al. 2001

Heart

View full text Add to dashboard Cite

Objectives-To assess whether patients with heart disease in a single UK hospital have equitable access to exercise testing, coronary angiography, and coronary artery bypass graft surgery (CABG). Method-Retrospective analysis of patients' medical case notes (n = 1790), tracking each case back 12 months and forward 12 months from the patient's date of entry to the study. Setting-Single UK district hospital in the Thames Region. Patients-Patients (elective and emergency) with a cardiac ICD inpatient code at discharge or death, or who were referred to cardiology or care of the elderly unit over a 12 month period in 1996-7 (new episodes) were included. Results-Analysis of 1790 hospital case notes revealed that, despite having indications for intervention identical to those of younger patients, older patients (that is, those aged > 75 years) and women, independently, were significantly less likely to undergo exercise tolerance testing (exercise ECG) and cardiac catheterisation. The similar trends for age and access to CABG did not achieve significance. While clinical priority scores also independently predicted access to cardiac catheterisation and CABG, considerable numbers of patients in high clinical priority groups were not referred for either procedure. Conclusions-The management and treatment of older patients and women with cardiac disease may be diVerent from that of younger patients and men. Given the similarity of the indications for treatment and the lack of significant contraindications or comorbidities as a cause for these diVerences, one possible explanation is that these patients are being discriminated against principally because of their age and sex. Although clinical priority scores independently predicted access to catheterisation and CABG, large proportions of patients in high priority groups were not referred. This implies that the New Zealand priority scoring system may be more equitable than UK practice. The cost implications of redressing these inequities in service provision would be considerable. (Heart 2001;85:680-686)

show abstract

Section: Methodsmentioning

confidence: 99%

Equity in access to exercise tolerance testing, coronary angiography, and coronary artery bypass grafting by age, sex and clinical indications

Bowling

Bond²,

McKee³

et al. 2001

Heart

View full text Add to dashboard Cite

show abstract

“…We measured severity of conditions, risk and criteria for intervention using the following criteria: Canadian Cardiovascular Society functional classification for angina related limitation on activities [12]; New York Heart Association scale [13]; Parsonnet 2 clinical risk score for heart surgery [14]; De Bono clinical priority criteria for cardiac catheterisation and coronary angioplasty [15]; and the New Zealand priority scores for urgency of CABG [16]. Indications for cardiological investigations and/or interventions were considered using the American College of Cardiology/American Heart Association (ACC/AHA) criteria [17,18].…”

Section: Data Collectionmentioning

confidence: 99%

Age- and sex-related utilisation of cardiac procedures and interventions: a multicentric study in Italy

Boccia¹,

Damiani²,

D'Errico³

et al. 2005

International Journal of Cardiology

View full text Add to dashboard Cite

“…Anonymized, non‐invasive clinical data were collected retrospectively, including demographics, family history of HCM/SCD, extra‐cardiac manifestations of each RASopathy syndrome, syndrome, genetic analysis results, heart failure symptoms [New York Heart Association (NYHA)/Ross functional classification 22 , 23 ], medication, resting and ambulatory 12‐lead electrocardiogram, and two‐dimensional Doppler and colour transthoracic echocardiogram (from contemporaneously written reports). Age at diagnosis was defined as the age at which HCM was first diagnosed, which may have been prior to the patient(s) being seen for the first time in a paediatric cardiology service.…”

Section: Methodsmentioning

confidence: 99%

Natural history and outcomes in paediatric RASopathy‐associated hypertrophic cardiomyopathy

Boleti,

Norrish,

Field

et al. 2024

ESC Heart Failure

View full text Add to dashboard Cite

AimsThis study aimed to describe the natural history and predictors of all‐cause mortality and sudden cardiac death (SCD)/equivalent events in children with a RASopathy syndrome and hypertrophic cardiomyopathy (HCM).Methods and resultsThis is a retrospective cohort study from 14 paediatric cardiology centres in the United Kingdom and Ireland. We included children <18 years with HCM and a clinical and/or genetic diagnosis of a RASopathy syndrome [Noonan syndrome (NS), NS with multiple lentigines (NSML), Costello syndrome (CS), cardiofaciocutaneous syndrome (CFCS), and NS with loose anagen hair (NS‐LAH)]. One hundred forty‐nine patients were recruited [111 (74.5%) NS, 12 (8.05%) NSML, 6 (4.03%) CS, 6 (4.03%) CFCS, 11 (7.4%) Noonan‐like syndrome, and 3 (2%) NS‐LAH]. NSML patients had higher left ventricular outflow tract (LVOT) gradient values [60 (36–80) mmHg, P = 0.004]. Over a median follow‐up of 197.5 [inter‐quartile range (IQR) 93.58–370] months, 23 patients (15.43%) died at a median age of 24.1 (IQR 5.6–175.9) months. Survival was 96.45% [95% confidence interval (CI) 91.69–98.51], 90.42% (95% CI 84.04–94.33), and 84.12% (95% CI 75.42–89.94) at 1, 5, and 10 years, respectively, but this varied by RASopathy syndrome. RASopathy syndrome, symptoms at baseline, congestive cardiac failure (CCF), non‐sustained ventricular tachycardia (NSVT), and maximal left ventricular wall thickness were identified as predictors of all‐cause mortality on univariate analysis, and CCF, NSVT, and LVOT gradient were predictors for SCD or equivalent event.ConclusionsThese findings highlight a distinct category of patients with Noonan‐like syndrome with a milder HCM phenotype but significantly worse survival and identify potential predictors of adverse outcome in patients with RASopathy‐related HCM.

show abstract

Major Changes Made by Criteria Committee of the New York Heart Association

Cited by 45 publications

References 0 publications

Equity in access to exercise tolerance testing, coronary angiography, and coronary artery bypass grafting by age, sex and clinical indications

Equity in access to exercise tolerance testing, coronary angiography, and coronary artery bypass grafting by age, sex and clinical indications

Age- and sex-related utilisation of cardiac procedures and interventions: a multicentric study in Italy

Natural history and outcomes in paediatric RASopathy‐associated hypertrophic cardiomyopathy

Contact Info

Product

Resources

About